Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19
Autor: | Jan Berg Gertsen, Anne Haglund, Karen Rokkedal Lausch, Lone Buus, Steffen Christensen, Lise Kristensen |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Hyperthermia 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 030106 microbiology 030231 tropical medicine Case Report Bacteremia Invasive pulmonary aspergillosis Microbiology 03 medical and health sciences 0302 clinical medicine medicine skin and connective tissue diseases lcsh:QH301-705.5 lcsh:R5-920 Aspergillus biology business.industry COVID-19 medicine.disease biology.organism_classification bacterial infections and mycoses respiratory tract diseases Infectious Diseases Increased risk lcsh:Biology (General) Immunology lcsh:Medicine (General) business |
Zdroj: | Haglund, A, Christensen, S, Kristensen, L, Gertsen, J B, Buus, L & Lausch, K R 2021, ' Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19 ', Medical Mycology Case Reports, vol. 31, no. Special issue, pp. 29-31 . https://doi.org/10.1016/j.mmcr.2020.11.004 Medical Mycology Case Reports Medical Mycology Case Reports, Vol 31, Iss, Pp 29-31 (2021) |
DOI: | 10.1016/j.mmcr.2020.11.004 |
Popis: | Severely ill influenza patients are at increased risk of invasive pulmonary aspergillosis (IPA). Previous reports suggest that Coronavirus Disease 2019 (COVID-19) patients may also be at increased risk of IPA. Here we present an Aspergillus co-infection in a COVID-19 immunocompetent patient, complicated by bacteremia and persistent hyperthermia. We describe the challenges in diagnosing IPA in COVID-19 immunocompetent patients and how the patient responded to the treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |
Pro tento záznam nejsou dostupné žádné jednotky.